The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Araújo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel F. Boyer, Maria Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee Joo Chng, John Kim Choi, Shih‐Sung Chuang, Sarah E. Coupland, Magdalena Czader, Sandeep S. Davé, Daphne de Jong, Ming‐Qing Du, Kojo S.J. Elenitoba‐Johnson, Judith A. Ferry, Julia Turbiner Geyer, Dita A. Gratzinger, Joan Guitart, Sumeet Gujral, Marian H. Harris, Christine J. Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph David Khoury, Hiroshi Kimura, Alexandra E. Kovach, Shaji Kunnathu Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, Leonard Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William George Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa P. Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, JONATHAN W. SAID, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben M. Tooze, Alexandra Traverse‐Glehen, Francisco Vega, Béatrice Vergier, Ashutosh D. Wechalekar, Brent Lee Wood, Luc Xerri, Wenbin Xiao
Leukemia · 2022 · 4,448 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araújo, I., Berti, E., Bhagat, G., Borges, A. M., Boyer, D. F., Calaminici, M., Chadburn, A., Chan, J. K. C., Cheuk, W., Chng, W. J., Choi, J. K., Chuang, S., Coupland, S. E., Czader, M., Davé, S. S., … Xiao, W. (2022). The 5th edition of the world health organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia, 36(7), 1720–1748. https://doi.org/10.1038/s41375-022-01620-2
In text: (Alaggio et al., 2022)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Abstract We herein present an overview of the upcoming 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4 th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5 th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Related papers
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms2016
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma2017
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification2014
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma2002
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia2002
Metadata from OpenAlex (CC0). Citations are generated from the published record.